• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌感染:2013 年概述,重点关注治疗。

Helicobacter pylori infection: an overview in 2013, focus on therapy.

机构信息

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China. Email:

出版信息

Chin Med J (Engl). 2014;127(3):568-73.

PMID:24451968
Abstract

OBJECTIVE

This article aimed to review the incidence of Helicobacter pylori (H. pylori) infection and its therapy.

DATA SOURCES

Relevant articles published in English were identified by searching in PubMed from 2000 to 2013, with keywords "H. pylori". Important references from selected articles were also retrieved from Elsevier, Wiley, EBSCO, and SPRINGER. The Chinese articles published were searched from China National Knowledge Infrastructure (CNKI).

STUDY SELECTION

Articles about "prevalence", "gastric carcinoma", "peptic ulcer", "gastroesophageal reflux disease", "functional dyspepsia", "pathogenic mechanism", "therapy", "eradication rate", "antibiotic resistance", and "gene polymorphisms" were selected.

RESULTS

The decreased infection rates of H. pylori could also be linked to the changed disease spectrum, such as the decreased morbidity and recurrence rate of H. pylori-related peptic ulcer, and the increased morbidity of gastroesophageal reflux. Although different treatment regimens have been used for H. pylori infection, the H. pylori eradication rate declined gradually. Due to primary resistance to antibiotics, the gene polymorphism of host and infected strain, and the therapy regimes, H. pylori eradication became even more difficult.

CONCLUSIONS

The prevalence of H. pylori infection had been decreasing, but the rate of eradication failure has dramatically risen in many countries due to resistance to antibiotic. H. pylori therapy in clinical practice is becoming progressively more difficult.

摘要

目的

本文旨在回顾幽门螺杆菌(H. pylori)感染及其治疗的发生率。

资料来源

通过在 2000 年至 2013 年期间在 PubMed 中以“ H. pylori”为关键词搜索,确定了以英文发表的相关文章。还从 Elsevier、Wiley、EBSCO 和 SPRINGER 检索了从选定文章中提取的重要参考文献。从中国国家知识基础设施(CNKI)中搜索了发表的中文文章。

研究选择

选择了有关“流行率”,“胃癌”,“消化性溃疡”,“胃食管反流病”,“功能性消化不良”,“发病机制”,“治疗”,“清除率”,“抗生素耐药性”和“基因多态性”的文章。

结果

H. pylori感染率的降低也可能与疾病谱的变化有关,例如与 H. pylori相关的消化性溃疡的发病率和复发率降低,以及胃食管反流病的发病率增加。尽管已经使用了不同的治疗方案来治疗 H. pylori感染,但是 H. pylori根除率逐渐下降。由于对抗生素的原发性耐药性,宿主和感染株的基因多态性以及治疗方案,H. pylori的根除变得更加困难。

结论

在许多国家,由于抗生素耐药性,H. pylori感染的流行率已经降低,但根除失败的比率却急剧上升。在临床实践中,H. pylori的治疗变得越来越困难。

相似文献

1
Helicobacter pylori infection: an overview in 2013, focus on therapy.幽门螺杆菌感染:2013 年概述,重点关注治疗。
Chin Med J (Engl). 2014;127(3):568-73.
2
Indications for treatment of Helicobacter pylori infection: a systematic overview.幽门螺杆菌感染的治疗指征:系统综述。
CMAJ. 1994 Jan 15;150(2):189-98.
3
[Helicobacter pylori-related diseases: dyspepsia, ulcers and gastric cancer].[幽门螺杆菌相关疾病:消化不良、溃疡和胃癌]
Gastroenterol Hepatol. 2011 Oct;34 Suppl 2:15-26. doi: 10.1016/S0210-5705(11)70017-6.
4
[Helicobacter pylori-related diseases].[幽门螺杆菌相关疾病]
Gastroenterol Hepatol. 2013 Oct;36 Suppl 2:39-50. doi: 10.1016/S0210-5705(13)70052-9.
5
[Long-term course of reflux symptoms following Helicobacter pylori eradication].[幽门螺杆菌根除后反流症状的长期病程]
Dtsch Med Wochenschr. 2004 Mar 26;129(13):671-5. doi: 10.1055/s-2004-820578.
6
[Genetic type of Helicobacter pylori and the efficacy of eradication therapy].[幽门螺杆菌的基因类型与根除治疗的疗效]
Pol Merkur Lekarski. 2009 Feb;26(152):105-9.
7
[Antibiotic resistance in Helicobacter pylori and molecular methods for the detection of resistance].[幽门螺杆菌的抗生素耐药性及耐药性检测的分子方法]
Mikrobiyol Bul. 2005 Jul;39(3):399-408.
8
The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.在初级卫生保健机构中,对十二指肠溃疡患者进行幽门螺杆菌筛查的作用。
Br J Gen Pract. 1996 Mar;46(404):177-9.
9
Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.溃疡患者根除幽门螺杆菌后1至3年的症状改善:胃食管反流病的影响
Am J Gastroenterol. 2000 Jan;95(1):101-5. doi: 10.1111/j.1572-0241.2000.01706.x.
10
Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.根除幽门螺杆菌感染可降低使用非甾体抗炎药患者消化性溃疡病的发病率:一项荟萃分析。
Helicobacter. 2012 Aug;17(4):286-96. doi: 10.1111/j.1523-5378.2012.00942.x. Epub 2012 Mar 20.

引用本文的文献

1
Knowledge and Perception of Physicians of Different Specialties in Saudi Arabia Toward .沙特阿拉伯不同专业医生对……的认知与看法
J Multidiscip Healthc. 2023 Mar 19;16:763-771. doi: 10.2147/JMDH.S403999. eCollection 2023.
2
A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China.中国食管癌高发地区基于人群的胃食管反流病调查。
Chin Med J (Engl). 2019 Jul 5;132(13):1516-1523. doi: 10.1097/CM9.0000000000000275.
3
Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism.
幽门螺杆菌根除:白细胞介素-1β-31C/T 多态性的影响。
Braz J Infect Dis. 2018 Jul-Aug;22(4):311-316. doi: 10.1016/j.bjid.2018.06.005. Epub 2018 Jul 24.
4
Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS).胃超声报告及数据系统(Su-RADS)评估类别初步意见。
Gastric Cancer. 2018 Sep;21(5):879-888. doi: 10.1007/s10120-018-0798-x. Epub 2018 Jan 25.
5
Helicobacter pylori colonization of the oral cavity: A milestone discovery.口腔幽门螺杆菌定植:一项里程碑式的发现。
World J Gastroenterol. 2016 Jan 14;22(2):641-8. doi: 10.3748/wjg.v22.i2.641.
6
Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication?治疗幽门螺杆菌感染患者的伴侣是否有优势?
Gastroenterol Res Pract. 2015;2015:706507. doi: 10.1155/2015/706507. Epub 2015 Mar 15.
7
Low dose furazolidone for eradication of H- pylori instead of clarithromycin: a clinical trial.低剂量呋喃唑酮替代克拉霉素根除幽门螺杆菌:一项临床试验
Glob J Health Sci. 2014 Aug 31;7(1):235-9. doi: 10.5539/gjhs.v7n1p235.
8
Therapy of Helicobacter pylori: present medley and future prospective.幽门螺杆菌的治疗:当前的混杂情况与未来展望
Biomed Res Int. 2014;2014:124607. doi: 10.1155/2014/124607. Epub 2014 Apr 1.